Breaking News

WuXi Biologics to Open Clinical Mfg. Facility in Cranbury, NJ

Will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions.

By: Contract Pharma

Contract Pharma Staff

WuXi Biologics has signed a 10-year lease for a clinical manufacturing facility (MFG18) in Cranbury, NJ. The new facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-sq.-ft. facility is expected to become operational in late 2020 and will add as many as 100 jobs to the region. WuXi Biologics’ also recently purchased land to build a new 107,000-sq.-ft. clinical and commercial manufacturing fa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters